Health Panel members
| Graham A. Colditz, Channing Laboratory, Boston, MA . |
|---|
| Martin Jarvis, Health Behaviour Unit of Cancer Research UK, Department of Epidemiology and Public Health, University College London, London, United Kingdom |
| Michael Kunze, Institute of Social Medicine, University of Vienna, Vienna, Austria |
| Freddi Lewin, Department Oncology, Huddinge University Hospital, Stockholm, Sweden |
| Jonathan M. Samet, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD |
| Peter Shields, Cancer Genetics and Epidemiology, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC |
| Steven D. Stellman, Mailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY |
| Michael Thun, Department of Epidemiology and Surveillance, American Cancer Society, Atlanta, GA |
| Deborah M. Winn, Epidemiology and Genetics Research Program, Division of Cancer Control and Population Sciences, NIH, Washington, DC |
| Graham A. Colditz, Channing Laboratory, Boston, MA . |
|---|
| Martin Jarvis, Health Behaviour Unit of Cancer Research UK, Department of Epidemiology and Public Health, University College London, London, United Kingdom |
| Michael Kunze, Institute of Social Medicine, University of Vienna, Vienna, Austria |
| Freddi Lewin, Department Oncology, Huddinge University Hospital, Stockholm, Sweden |
| Jonathan M. Samet, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD |
| Peter Shields, Cancer Genetics and Epidemiology, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC |
| Steven D. Stellman, Mailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY |
| Michael Thun, Department of Epidemiology and Surveillance, American Cancer Society, Atlanta, GA |
| Deborah M. Winn, Epidemiology and Genetics Research Program, Division of Cancer Control and Population Sciences, NIH, Washington, DC |